FDA Panel Backs Pre-Surgery Drug for Breast Cancer

FDA Panel Backs Pre-Surgery Drug for Breast Cancer

A federal advisory committee cleared the way on Thursday for the first approval of a cancer drug that would be used to treat patients before surgery to remove their tumors. The advisory committee to the Food and Drug Administration voted 13 to 0, with

5
Like
Save

Comments

Write a comment

*